[Control of cisplatin-induced delayed emesis].
Despite excellent control of acute-stage emesis, some patients are still bothered by delayed emesis occurring more than 24 hours after cisplatin administration. We report 19 patients with 61 courses of cisplatin-based chemotherapy. They all received high-dose metoclopramide, dexamethasone and lorazepam on the day of cisplatin treatment. After 24 hours, they were treated with intravenous dexamethasone 8 mg once and metoclopramide 50 mg twice on day 2, and oral metoclopramide 10 mg qid on days 3-5. Delayed vomiting and nausea were noted in 27.9% and 39.4% respectively, as compared with 69.8% of delayed emesis and 79.4% of delayed nausea in 63 courses of 15 patients without receiving any antiemetics on days 2-5. The statistics showed significant difference (both P less than 0.001). Side effects were mild and acceptable. Therefore, this regimen is highly effective in preventing delayed vomiting and nausea.
Li
Y T
YT
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital.
Mau
Y K
YK
Hsu
K P
KP
D002945:Cisplatin / Q000009:adverse effects*; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D013997:Time Factors; D014839:Vomiting / Q000517:prevention & control*
D003907:Dexamethasone; D008787:Metoclopramide; D002945:Cisplatin